Federal Reserve officials are expected to cut interest rates by a quarter of a percentage point on Thursday because inflation ...

Guy on Rocks’ is a Stockhead series looking at the significant happenings of the resources market each week. Former geologist ...

The peer-reviewed publication Metallomics supports the mechanism of action of Alterity’s neurological drug candidate Respiri ...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

ASX healthcare stocks underperform, but optimism grows as Uscom, Respiri, Hitiq report mixed results and Artrya, Nyrada make ...

Alkane boss Nic Earner lays down the case for self-sufficient exploration to production with insights into his company’s ...

With their innovative tech ASX medical imaging companies are capitalising on the lucrative opportunity of caring for US ...

The ASX kicked off Wednesday with a bang, up by 0.82% and mirroring a strong rally from Wall Street where tech heavyweights ...

Dengue fever is spreading to cooler climates and geographies such as California Attempts to develop treatments have been ...

Former Rio and Arcelor Mittal man Paul Berend says the iron ore outlook is brighter than many think for new developers.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Sarah Hughan tells all on Auking Mining’s (ASX:AKN) gold exploration licence in Saudi Arabia ...

Aussie shares slipped into the red on Tuesday, falling 0.4% as sentiment remained subdued after the Reserve Bank of Australia ...